NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $687,445 | +19.3% | 7,578 | +0.0% | 0.35% | -2.8% |
| Q3 2022 | $576,000 | -10.0% | 7,577 | 0.0% | 0.36% | +8.8% |
| Q2 2022 | $640,000 | +14.3% | 7,577 | +18.8% | 0.33% | +7.8% |
| Q1 2022 | $560,000 | -4.9% | 6,377 | -5.3% | 0.31% | +15.0% |
| Q4 2021 | $589,000 | -7.8% | 6,737 | -13.7% | 0.27% | -12.2% |
| Q3 2021 | $639,000 | -10.4% | 7,810 | 0.0% | 0.30% | -23.6% |
| Q2 2021 | $713,000 | +4.1% | 7,810 | -2.5% | 0.40% | +1.0% |
| Q1 2021 | $685,000 | -18.2% | 8,010 | -9.7% | 0.39% | -32.2% |
| Q4 2020 | $837,000 | +4.8% | 8,868 | -3.5% | 0.58% | -16.6% |
| Q3 2020 | $799,000 | -1.2% | 9,193 | -0.8% | 0.70% | -6.2% |
| Q2 2020 | $809,000 | +6.4% | 9,263 | +0.5% | 0.74% | -36.7% |
| Q1 2020 | $760,000 | -12.4% | 9,213 | +0.5% | 1.17% | +80.3% |
| Q4 2019 | $868,000 | – | 9,163 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
| PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
| MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
| Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
| BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
| SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
| PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
| Elefante Mark B | 5,619 | $417,000 | 3.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
| CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |